Skip to main content

Abstract

It has become increasingly apparent that aspirin induces a marked delay in the aggregation properties of platelets. It causes an inhibition of collagen-induced platelet aggregation in association with and probably due to a decreased release of ADP. This occurs in vitro. The response of platelets to epinephrine-induced release of ADP in the second wave of aggregation is also blocked by aspirin. In addition, the drug inhibits both collagen and ADP-induced activation of platelet factor III (phospholipid-like factor) and the release of platelet factor IV in vitro and in vivo, but does not impair the response to thrombin. These effects are uniquely confined to aspirin, since sodium salicylate neither prolongs the bleeding time nor significantly inhibits platelet ADP release.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Boston Collaborative Drug Surveillance Group: Regular aspirin intake and acute myorcardial infarction. Brit. med. J. 1, 440–443 (1974)

    Article  Google Scholar 

  • Elwood, P.C., Cochrane, A.L., Burr, M.L., Sweetman, P.M., Williams, G., Welsby, E., Hughes, S.J., Renton, R.: A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Brit. med. J. 1, 436–440 (1974)

    Article  PubMed  CAS  Google Scholar 

  • Evans, G., Packham, M.A., Mustard, J.F.: Chapter VII, Thromboembolism. In: Aspirin, Platelets and Stroke. Fields, W.S., Hass, W.K. (eds.). St. Louis Mo.: Warren H. Green, Inc. 1970

    Google Scholar 

  • Evans, G.: Effect of platelet-suppressive agents on the incidence of amaurosis fugax and transient cerebral ischemia. In: Cerebral Vascular Diseases. 8th Conference, McDowell, F.H., Brennan, R.W. (eds.). New York: Grune and Stratton 1973

    Google Scholar 

  • Stuart, R.K.: Platelet function studies in human beings receiving 300 mg of aspirin per day. J. Lab. clin. Med. 75, 463–471 (1970)

    PubMed  CAS  Google Scholar 

  • Weiss, H.J., Danese, C.A., Voletti, C.D.: Prevention of experimentally induced arterial thrombosis by aspirin. Fed. Proc. 29, 381 (1970)

    Google Scholar 

  • Zucker, M.B., Peterson, J.: Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents and dipyridamole on human blood platelets. J. Lab. clin. Med. 76, 66–75 (1970)

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fields, W.S., Callen, P.W., Preslock, M.M. (1977). Aspirin in Cerebral Ischemia. In: Agnoli, A., Fazio, C. (eds) Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66609-4_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66609-4_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-66611-7

  • Online ISBN: 978-3-642-66609-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics